The human CYP3A subfamily is of interest due to its multiplicity, acti
vity toward known carcinogens, and extrahepatic expression. In situ hy
bridisation analysis of formalin fixed, routinely processed biopsy spe
cimens was used to localise CYP3A mRNA in human gastrointestinal tissu
es from several individuals. CYP3A mRNA is abundant in human liver and
in mucosal epithelial cells of all segments of the human small intest
ine. RNA blot analyses showed that the mRNA species observed in most l
ivers and in human small intestine represent CYP3A3/3A4 transcripts. T
his was confirmed at the protein level by immunoblot comparison of sma
ll intestine microsomes to in vitro expressed CYP3A4 and CYP3A5 protei
ns. In liver and small intestine, CYP3A mRNA is not uniformly distribu
ted, with grain density highest in cells within the respective non-pro
liferative compartments. CYP3A mRNA was also observed in human oesopha
gus and colon. RNA blot analysis of multiple colons showed heterogenei
ty in the CYP3A mRNAs present. Two CYP3A mRNAs (CYP3A3/3A4 and CYP3A5)
were detected in colon samples from several individuals. In addition
to those localisation studies, the capacity of expressed CYP3A4 and CY
P3A5 to activate the dietary heterocyclic amine MeIQ in the presence o
f alpha-naphthoflavone was shown. These results show that there is con
siderable heterogeneity in the expression of the CYP3A subfamily in hu
man gastrointestinal tissues.